Tag: RP2D
In a phase 2a research using Lenvima and fostrox to treat hepatocellular cancer, Medivir has started treating patients.
The first patient with hepatocellular carcinoma (HCC) has begun treatment in phase 2a with the candidate drug fostroxacitabine…
